| Mar-2025 | Dec-2024 | Dec-2024 | Dec-2024 | Nov-2024 | |
|---|---|---|---|---|---|
Promoter | - | - | - | - | - |
Foreign | 0% | 0% | 0% | 0% | 7.82% |
Indian | 48.78% | 61.06% | 48.78% | 48.78% | 53.23% |
Total Promoter | - | - | - | - | - |
Institutions | 36.51% | 38.93% | 32.32% | 35.82% | 0% |
Non-Institutions | 14.7% | 0% | 18.89% | 15.39% | 0% |
Total Non-Promoter | 51.21% | 38.93% | 51.21% | 51.21% | 0% |
Custodian | 0% | 0% | 0% | 0% | 38.93% |
Total | 100% | 100% | 100% | 100% | 100% |
Suraksha Diagnostics specializes in medical consultancy services, hoping to attract investors in the rising healthcare sector
The anchor book, available to institutional investors, will open a day earlier, on November 28, 2024.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
